A Study Evaluating Multiple Ascending Doses of QRL-101 in Healthy Participants
NCT06532396
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
QRL-101
DRUG:
Placebo
Sponsor
QurAlis Corporation